EQS-News: MorphoSys AG / Key word: Annual Report
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
13.03.2024 / 21:01.
Death in Cancer Drug Trial Hinders Xencor's Shares - Los Angeles Business Journal labusinessjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labusinessjournal.com Daily Mail and Mail on Sunday newspapers.
Knight Therapeutics Announces Launch of Minjuvi® in Brazil marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Profund Advisors LLC trimmed its holdings in shares of Xencor, Inc. (NASDAQ:XNCR – Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,541 shares of the biopharmaceutical company’s stock after selling 3,105 shares during the […]
Knight Therapeutics Announces Launch of Minjuvi® in Brazil streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.